Target Name: ACTL9
NCBI ID: G284382
Review Report on ACTL9 Target / Biomarker Content of Review Report on ACTL9 Target / Biomarker
ACTL9
Other Name(s): ACTL7C | actin like 9 | ACTL9_HUMAN | Actin like 9 | HSD21 | testicular tissue protein Li 15 | testicular tissue protein Li 9 | Actin-like protein 9 | SPGF53

Function and role of Actinin-family protein ACTL9

ACTL9 (ACTL7C) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the actinin family, which is known for their role in cell-cell adhesion and cytoskeletal organization.

Recent studies have identified ACTL9 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to its unique structure and the various functions that it is known to play in the body.

One of the key functions of ACTL9 is its role in cell-cell adhesion. This is important for the development and maintenance of tissues, as well as for the regulation of various physiological processes. ACTL9 is known to be involved in the formation of tight junctions, which are the gaps that form between cells and are essential for proper communication and signaling.

In addition to its role in cell-cell adhesion, ACTL9 is also involved in the regulation of cytoskeletal organization. This is important for the proper structure and function of cells, as well as for the regulation of various physiological processes. ACTL9 is known to be involved in the formation of microtubules, which are the structural elements that give cells their shape and stability.

Another function of ACTL9 is its role in the regulation of cellular signaling pathways. This is important for the development and maintenance of tissues, as well as for the regulation of various physiological processes. ACTL9 is known to be involved in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway.

In addition to its role in cell-cell adhesion, cytoskeletal organization, and cellular signaling pathways, ACTL9 is also involved in the regulation of inflammation. This is important for the development and maintenance of tissues, as well as for the regulation of various physiological processes. ACTL9 is known to be involved in the regulation of inflammation and the immune response.

Overall, ACTL9 is a protein that plays a crucial role in the development and maintenance of tissues, as well as for the regulation of various physiological processes. As a potential drug target, ACTL9 has the potential to be used to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Protein Name: Actin Like 9

Functions: Testis-specic protein that plays an important role in fusion of proacrosomal vesicles and perinuclear theca formation

The "ACTL9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACTL9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ACTMAP | ACTN1 | ACTN1-DT | ACTN2 | ACTN3 | ACTN4 | ACTR10 | ACTR1A | ACTR1B | ACTR2 | ACTR3 | ACTR3B | ACTR3BP2 | ACTR3BP5 | ACTR3BP6 | ACTR3C | ACTR5 | ACTR6 | ACTR8 | ACTRT1 | ACTRT2 | ACTRT3 | ACVR1 | ACVR1B | ACVR1C | ACVR2A | ACVR2B | ACVR2B-AS1 | ACVRL1 | ACY1 | ACY3 | Acyl-CoA dehydrogenase (ACAD) | Acyl-CoA Synthetase Short-Chain | ACYP1 | ACYP2 | ADA | ADA2 | ADA2A-containing complex (ATAC) | ADAD1 | ADAD2 | ADAL | ADAM10 | ADAM11 | ADAM12 | ADAM15 | ADAM17 | ADAM18 | ADAM19 | ADAM1A | ADAM1B | ADAM2 | ADAM20 | ADAM20P1 | ADAM21 | ADAM21P1 | ADAM22 | ADAM23 | ADAM28 | ADAM29 | ADAM30 | ADAM32 | ADAM33 | ADAM3A | ADAM5 | ADAM6 | ADAM7 | ADAM7-AS1 | ADAM7-AS2 | ADAM8 | ADAM9 | ADAMDEC1 | ADAMTS1 | ADAMTS10 | ADAMTS12 | ADAMTS13 | ADAMTS14 | ADAMTS15 | ADAMTS16 | ADAMTS16-DT | ADAMTS17 | ADAMTS18 | ADAMTS19 | ADAMTS2 | ADAMTS20 | ADAMTS3 | ADAMTS4 | ADAMTS5 | ADAMTS6 | ADAMTS7 | ADAMTS7P1 | ADAMTS7P3 | ADAMTS7P4 | ADAMTS8 | ADAMTS9 | ADAMTS9-AS1 | ADAMTS9-AS2 | ADAMTSL1 | ADAMTSL2 | ADAMTSL3 | ADAMTSL4